explore -WSS

explore

author：hotspot 2025-09-29 16:35:18 - browse：57

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Allen Institute goes after foundational questions, CEO Costa says

explore

WSS

Nonprofit, backed by Microsoft, to certify AI tools in health care

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Donor acceptance rates hint at racial, gender bias in heart transplants: study

STAT Virtual Event: JPM Recap, Live!

Hospital chaplains balance Covid safety with patients’ spiritual needs

American taxpayers paid $1.8 trillion in health care costs in 2022

Wikipedia

explore

explore

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Merck, Vertex, and Viking updates

Jerome Adams on the need for new antivirals for Covid

Profiling embryos to choose those with higher IQs is almost a reality

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Washington mulls new rules to avert another Change Healthcare

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Covid vaccine financial winners and losers, from Pfizer to Novavax

Trump demands the U.S. pay no more for drugs than other countries … again

Stories you might have missed in 2023: health, science, medicine

entertainment

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Stories you might have missed in 2023: health, science, medicine

Roche subsidiary Foundation Medicine opens new headquarters

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Gene therapy denied for Afghan refugee whose father aided U.S.

Wikipedia

knowledge

explore

entertainment